Cardiac autonomic neuropathy (CAN) is a common complication of diabetes mellitus, and
can be assessed using heart rate variability (HRV) and the correlations between systolic …

Abnormalities in heart rate (HR) variability (HRV) and blood pressure (BP) variability may
increase the risk of cardiovascular diseases. A well-known risk factor for cardiovascular …

The basis for the pathogenesis of cardiovascular, cancer, metabolic diseases, low-grade
chronic inflammation (LGCI) and many other disorders is an imbalance between prooxidants …

Cardiac autonomic neuropathy (CAN) is closely associated with an approximately five-fold
increase in the risk of cardiovascular mortality in patients with diabetes mellitus (DM) …

Diabetic cardiac autonomic neuropathy (DCAN) is a severe complication of type 1 diabetes
mellitus (T1DM) characterized by autonomic nerve fiber dysfunction in the heart and blood …

Основою патогенезу серцево-судинних, онкологічних, метаболічних захворювань,
хронічного запалення низької інтенсивності (ХЗНІ) та багатьох інших розладів є …

Background. Cardiac autonomic neuropathy is a serious complication of diabetes mellitus
that is strongly associated with approximately five-fold increased risk of cardiovascular …

The significance of cardiac autonomic neuropathy (CAN) in patients with type 2 diabetes
mellitus (T2DM) has been not fully appreciated and there is no unified treatment algorithm …

Bempedoic acid is a new cholesterol-lowering drug that recently received approval from the
US Food and Drug Administration and the European Medicines Agency. This drug targets …

Background: Currently, there is no unified treatment algorithm of cardiac autonomic
neuropathy (CAN) in patients with type 2 diabetes mellitus (T2DM). The aim of this study was …